Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Fomepizole

Generic name
Fomepizole
Brand name
ATC Code
VO3AB34

Pharmacokinetics in children

No information

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Available formulations

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Dosages

Acute ethylene glycol intoxication
  • Intravenous
    • 1 month up to 18 years
      [1]

      • Start:15 mg/kg/dose

        Subsequent doses:
        second dose (12 hours after starting): 10 mg/kg/dose
        third dose (24 hours after starting): 10 mg/kg/dose
        fourth dose (36 hours after starting): 10 mg/kg/dose
        fifth dose (48 hours after starting): 7.5–15 mg/kg/dose
        sixth dose (60 hours after starting): 5-15 mg/kg/dose
        Administer over 30-45 minutes.

        Until the ethylene glycol levels have dropped to below 0.2 g/l (3.2 mmol/l).
        The number of maintenance doses and the dosage after 48 hours will depend on the initial concentration and the progression of the ethylene glycol levels over time. In general, 4 to 5 maintenance doses are recommended for initial ethylene glycol levels of between 3 and 6 g/l (48 to 96 mmol/l) and 1 to 3 maintenance doses are recommended for initial ethylene glycol levels of between 0.35 and 1.5 g/l (5.6 to 24 mmol/l)

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Reference

  1. Eusa Pharma, SPC Fomepizole (RVG 26970) 21/07/11, www.cbg-meb.nl, Geraadpleegd 23 okt 2014

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Changes

Changes